Bernard Verrier

发表

Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display

Véronique Josserand, Charles Vragniau, Joshua C Bufton, 2019, Science Advances.

Support for the RV144 HIV Vaccine Trial

Frances Gotch, Bernard Verrier, Pontiano Kaleebu, 2004, Science.

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Karine Labadie, Patricia Brochard, Roger Le Grand, 2010, The Journal of clinical investigation.

Evolutionary Dynamics of the Glycan Shield of theHuman Immunodeficiency Virus Envelope during Natural Infection andImplications for Exposure of the 2G12Epitope

Bernard Verrier, Francis Barin, A. Moreau, 2004, Journal of Virology.

Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro

Frédéric Tangy, Bernard Verrier, O. Schwartz, 2014, Journal of Virology.

Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.

Patrice Gouet, Bernard Verrier, Marc Bossus, 2011, Journal of molecular biology.

Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation.

Bernard Verrier, Céline Lacroix, C. Lacroix, 2019, Biomaterials.

Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties.

Stéphane Paul, Thierry Lioux, Christian Genin, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.

Bernard Verrier, Concepción Marañón, Peter Ponsaerts, 2006, Blood.

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

Roger Le Grand, Céline Terrat, Bernard Verrier, 2006, Journal of controlled release : official journal of the Controlled Release Society.

UV and X‐ray structural studies of a 101‐residue long Tat protein from a HIV‐1 primary isolate and of its mutated, detoxified, vaccine candidate

Patrice Gouet, Alain Beck, Bernard Verrier, 2010, Proteins.

Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination.

Bernard Verrier, Philippe Roingeard, P. Roingeard, 2009, Vaccine.